SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-144827
Filing Date
2019-05-13
Accepted
2019-05-13 08:02:04
Documents
2
Effectiveness Date
2019-05-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A d743214ddefa14a.htm DEFA14A 17626
2 GRAPHIC g743214prot.jpg GRAPHIC 8411
  Complete submission text file 0001193125-19-144827.txt   30346
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEFA14A | Act: 34 | File No.: 001-37695 | Film No.: 19816926
SIC: 2834 Pharmaceutical Preparations